✦ LIBER ✦

Results of a phase II study combining, weekly irinotecan with pharmacokinetics (PK) adaptation of 5FU “Gamelin” schedule in first line in patients with metastatic colorectal cancer (MCRC)

✍ Scribed by Gamelin, E.; Jacob, J.; Boisdron, M.; Burtin, P.; Dorval, E.; Berger, V.; Ferment, O.; Couteau, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

664 PUBLICATION Cetuximab in combination

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A phase II study of irinotecan (CPT-11)

✍ Rosati, G.; Tucci, A.; Rinaldi, A.; Colarusso, D.; Rossi, A.; Pizza, C.; Manzion 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A randomized phase II trial assessing ir

✍ C. Pozzo; S. Pyrhönen; I. Bodrogi; J. Szanto; H. Kamica-Mlodkowska; H. Starkamma 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Capecitabine in combination with irinote

✍ Garcia-Alfonso, P; Muñoz-Martin, A; Mendez-Ureña, M; Quiben-Pereira, R; Gonzalez 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Results of a Phase II Open-Label Study o

✍ Thomas Cartwright; Timothy Lopez; Svetislava J. Vukelja; Carlos Encarnacion; Kri 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 485 KB

CPT-11 in combination with capecitabine

✍ Kerr, D.J.; Ten Bokkel Huinink, W.W.; Bakker, J.; Boussard, B.; Frings, S.; Nort 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB